Angiogenesis Assays: Problems and Pitfalls

Abstract

Many studies of angiogenesis inducers and inhibitors rely on in vitro or in vivo models as indicators of efficacy. However, as valuable as these models are, there are limitations to each one of these. This overview describes some of the principal methods now in use and discusses the advantages and some of the limitations of these methods. It is suggested that multiple assays, involving both in vitro and in vivo assays, are at present the best way to minimize the problems inherent in any specific assay.

DOI: 10.1023/A:1026574416001
050'02'04'06'08'10'12'14'16
Citations per Year

308 Citations

Semantic Scholar estimates that this publication has 308 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Auerbach2000AngiogenesisAP, title={Angiogenesis Assays: Problems and Pitfalls}, author={Robert Auerbach and Nasim Mohammad Akhtar and Rachel L. Lewis and Brenda L. Shinners}, journal={Cancer and Metastasis Reviews}, year={2000}, volume={19}, pages={167-172} }